A mother sued her daughters for control of a vaccine giant. The Supreme Court had a surprise fix.

Dr. Renuka Datla wanted control of Biological E. Ltd., the vaccine company her father founded. The Supreme Court gave her something else.

She got ₹65 lakh every month. A lump sum of ₹10 crore. A lifetime appointment as Emeritus Consultant — a title with dignity but no power. A promise that her daughters would never have to fight her in court again.

She did not get the company.

The question that hung over the case was simple and brutal: When a founder's daughter inherits 81% of a vaccine giant, does the founder's widow get to run it? The Supreme Court's answer reshaped how family businesses in India end their wars.

When the father's Will split the family

Biological E. Ltd. was founded in 1953 by Dr. Renuka Datla's father. It grew into one of India's most important vaccine manufacturers, supplying millions of doses every year. By the time the founder's son, Dr. Vijay Kumar Datla, took over as Chairman and Managing Director, the company was a national asset.

In 2005, Dr. Vijay Kumar Datla executed a Will. He died in March 2013. When the Will was read — the document felt thin in the hands of the family lawyer, its pages carrying the weight of a man's final decision — his three daughters discovered that their father had left his entire 81% shareholding — the controlling stake in the company — to the eldest daughter, Mahima Datla.

Board meetings were held in the company's boardroom, the long table polished and silent as the daughters signed the resolutions. Shares were transferred to Mahima. All three daughters were appointed directors. The company continued to operate as it had under their father.

Then Dr. Renuka Datla, the mother, challenged everything.

Three rounds, three different outcomes

The mother approached the Company Law Board (CLB — a tribunal that hears disputes within companies) claiming that the board meetings were invalid and that her daughters were oppressing her and mismanaging the company. She filed a petition under Sections 397 and 398 of the Companies Act, 1956 (provisions that allow a shareholder to seek relief when a company's affairs are being conducted in a way that is oppressive or prejudicial to public interest).

The CLB dismissed her petition in May 2016. No oppression. No mismanagement. The board meetings were valid. The daughters were running the company properly. The CLB's order, a thick stack of paper, sat on the desk, its conclusion clear.

The mother appealed to the High Court of Judicature at Hyderabad under Section 10-F of the Companies Act, 1956 (the provision that allows appeals against CLB orders on questions of law). In November 2017, the High Court reversed the CLB completely. It declared the board meetings void. It removed the daughters from the board. It gave the mother control of the company.

The daughters appealed to the Supreme Court.

What the Supreme Court saw that the High Court missed

The Supreme Court bench — Justice Vineet Saran and Justice J.K. Maheshwari — identified three fundamental errors in the High Court's order.

First, the High Court had re-examined the entire evidence. Under Section 10-F, the High Court's jurisdiction is limited to questions of law. It cannot act as a second trial court, re-weighing every document and witness statement. The CLB had heard the evidence, seen the witnesses, and made its findings. The High Court had no power to redo that work.

Second, the High Court had decided questions of inheritance. Who gets what under a Will is a civil dispute — a matter for a regular civil court, not for a company law tribunal hearing an oppression petition. The Supreme Court held that questions of title and inheritance of shares are "alien to proceedings under Sections 397/398" and cannot be adjudicated in oppression or mismanagement petitions. A company law forum cannot decide who owns the shares; it can only decide how the company is being run.

Third, the High Court had directed that the mother be appointed as a whole-time director despite her being over 70 years of age. Under Section 196 read with Schedule V of the Companies Act, 2013, no person can be appointed as a whole-time director after the age of 70 unless a special resolution (a resolution passed by at least 75% of shareholders) approves it. The High Court had no power to override a statutory requirement. A court cannot direct a company to violate the law.

The Duomatic Principle: when all members agree, formalities can wait

The Supreme Court also applied a principle from English company law that had rarely been tested in India: the Duomatic Principle (the rule that if all shareholders with voting rights consent to a transaction, the lack of a formal board meeting does not make the transaction invalid).

The principle comes from a 1969 English case, In Re: Duomatic Ltd., where the court held that where all members of a company with a right to attend and vote at a general meeting assent to a matter, that matter is as binding as if it had been passed at a formal meeting.

The Supreme Court held that the Duomatic Principle applies in India, provided the transactions are bona fide (done in good faith) and no fraud is alleged. In this case, all three daughters — who together held 100% of the voting shares after the Will — had consented to the board meetings and the transfer of shares. There was no allegation of fraud. The meetings were valid even without strict adherence to every procedural requirement. The courtroom fell silent as the bench read this finding — a quiet that seemed to underline the finality of the daughters' consent.

The settlement that ended the war

The Supreme Court did not simply set aside the High Court order. It brokered a settlement that gave the mother financial security without giving her control of the company. The order, dated 6 April 2022, in Civil Appeal No. 2776-2778 of 2022, was read out in a hushed courtroom.

Dr. Renuka Datla was appointed Emeritus Consultant to the company — a lifetime position with dignity but no operational authority. She would receive ₹65 lakh per month starting 1 April 2022. She would get a lump sum of ₹10 crore by 31 May 2022. The company would provide medical facilities, security, a residence, and other amenities. A resolution to formalise these arrangements would be passed within one month. Both sides gave mutual undertakings to end all litigation.

The CLB order was restored. The daughters remained in control. The mother received what she needed without running what she wanted.

THE PLAY: When all shareholders consent to a transaction, the absence of a formal board meeting does not invalidate it — but only if the transaction is bona fide and no fraud is alleged.

The mother walked away with ₹65 lakh a month and a lifetime of care. The daughters walked away with the company their grandfather built. The Supreme Court walked away with a template for ending family wars without winners or losers.